{"url_path":"/sec/xtnt/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1453593/0001493152-26-022604-index.html","accession_number":"0001493152-26-022604","cik":"0001453593","ticker":"XTNT","issuer_name":"Xtant Medical Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1453593/0001493152-26-022604-index.html","primary_entity_key":"0001453593","primary_entity_name":"Xtant Medical Holdings, Inc."},"word_count":28,"has_tables":true,"body_markdown":"**ITEM\n1.**\n**Legal\nProceedings**\n\n \n\nOur\nlegal proceedings are discussed in Note 12, “*Commitments and Contingencies,*” in the notes to our condensed consolidated\nfinancial statements in this Form 10-Q."}